GlassScriptPhysician profile
Klara Vogel
NPI 1225120348
$5,860.97
in general payments reported to CMS, 2019-2025
46 companies · $1,086 in 2025
The $1,086 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $876 · 2020: $429 · 2021: $951 · 2022: $960 · 2023: $951 · 2024: $609 · 2025: $1,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,645.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,051.58 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Evofem Biosciences, INC. | $469.65 | 2021-2025 | Phexxi, Solosec, Phexx |
| Bayer Healthcare Pharmaceuticals INC. | $378.07 | 2019-2025 | |
| Agile Therapeutics, INC. | $334.33 | 2021-2024 | Twirla |
| Mayne Pharma Commercial LLC | $303.82 | 2022-2025 | |
| Coopersurgical, INC. | $299.10 | 2019-2025 | Paragard T 380a, Paragard T 380a, Summit Doppler |
| Amgen INC. | $267.23 | 2019-2024 | Evenity, Prolia |
| Therapeuticsmd, INC. | $235.09 | 2019-2022 | |
| Pfizer INC. | $201.85 | 2019-2025 | |
| Hologic Sales and Service, LLC | $186.07 | 2019-2025 | Aptima, Thinprep 2000 Processor, Coolseal Generator |
| Aspira Women'S Health INC | $162.67 | 2020-2024 | Ova1 |
| Allergan, INC. | $143.51 | 2019-2020 | |
| Exeltis, USA INC. | $133.86 | 2020-2024 | Slynd |
| Baxter Healthcare | $122.49 | 2023-2025 | Perclot, Floseal |
| Sage Therapeutics, LLC | $117.52 | 2025 | Zurzuvae |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $117.29 | 2024 | Wegovy |
| Astellas Pharma US INC | $112.36 | 2024-2025 | Veozah |
| Recordati_rare_diseases_inc. | $103.57 | 2025 | Isturisa |
| Daiichi Sankyo INC. | $102.93 | 2021-2022 | |
| Exact Sciences Corporation | $99.79 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Myovant Sciences INC. | $88.28 | 2021-2022 | |
| Lupin INC. | $77.82 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $63.56 | 2019-2022 | |
| Lilly USA, LLC | $61.68 | 2025 | Zepbound, Mounjaro |
| Nevro Corp. | $59.40 | 2019 | |
| Abbott Laboratories | $42.80 | 2023 | Proclaim |
| Supernus Pharmaceuticals, INC. | $41.85 | 2025 | Qelbree |
| Smith+Nephew, INC. | $41.23 | 2023 | Pico |
| Vertical Pharmaceuticals, LLC | $39.34 | 2019 | |
| Millicent US INC | $36.66 | 2025 | Intrarosa, Femlyv |
| Ascend Therapeutics US, LLC | $36.40 | 2023-2024 | |
| Convatec INC. | $36.06 | 2019 | |
| Seqirus USA INC | $33.51 | 2023 | Flucelvax Quadrivalent |
| Vertex Pharmaceuticals Incorporated | $33.46 | 2025 | |
| Scynexis, INC. | $31.45 | 2022 | |
| Sanofi Pasteur INC. | $27.26 | 2024 | |
| Duchesnay USA Incorporated | $22.08 | 2019 | |
| Cepheid | $19.78 | 2025 | Genexpert |
| Neuronetics, INC. | $17.65 | 2023 | Neurostar Tms Therapy System |
| Roche Diagnostics Corporation | $17.53 | 2020 | |
| Amag Pharmaceuticals, INC. | $16.20 | 2019 | |
| Alydia Health | $16.11 | 2021 | |
| Organon LLC | $15.27 | 2024 | |
| Becton, Dickinson and Company | $14.89 | 2022 | |
| Avion Pharmaceuticals | $14.55 | 2021 | |
| Almatica Pharma LLC | $13.37 | 2024 | Teriparatide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Klara Vogel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.